Nebulized 5% or 3% Hypertonic or 0.9% Saline for Treating Acute Bronchiolitis in Infants

Objective To compare the efficacy and safety of 5%, 3%, and 0.9% saline solution for treating acute bronchiolitis in the prehospital setting. Study design This was a double-blind trial including consecutive infants aged

Saved in:
Bibliographic Details
Published in:The Journal of pediatrics 2010-10, Vol.157 (4), p.630-634.e1
Main Authors: Al-Ansari, Khalid, MD, FRCPC, FAAP(PEM), Sakran, Mahmoud, MD, Davidson, Bruce L., MD, MPH, El Sayyed, Rafah, MD, Mahjoub, Hella, MD, Ibrahim, Khalid, MD
Format: Article
Language:English
Subjects:
Acute Disease
Administration, Inhalation
Ambulatory Care
Biological and medical sciences
Bronchiolitis - drug therapy
Bronchiolitis - epidemiology
Bronchiolitis - virology
Bronchodilator Agents - administration & dosage
Bronchodilator Agents - therapeutic use
Chronic obstructive pulmonary disease, asthma
Double-Blind Method
Female
General aspects
Humans
Infant
Male
Medical sciences
Nebulizers and Vaporizers
Pediatrics
Pneumology
Respiratory Syncytial Virus Infections - complications
Respiratory Syncytial Virus Infections - drug therapy
Respiratory Syncytial Viruses - isolation & purification
Saline Solution, Hypertonic - administration & dosage
Saline Solution, Hypertonic - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To compare the efficacy and safety of 5%, 3%, and 0.9% saline solution for treating acute bronchiolitis in the prehospital setting. Study design This was a double-blind trial including consecutive infants aged
ISSN:0022-3476
1097-6833
DOI:10.1016/j.jpeds.2010.04.074